Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

Clinical trial NCT06052527 · COMPLETED

Trial details

NCT number: NCT06052527
Sponsor: Lizora LLC
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Post-COVID-19 Syndrome Influenza

Start date: 2023-06-16
Primary completion: 2023-09-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.